Zimmer Holdings, Inc. (ZMH)

pos +0.14
Today's Range: 114.36 - 115.74 | ZMH Avg Daily Volume: 0
Last Update: 12/22/14 - 4:00 PM EST
Volume: 627,809
YTD Performance: 0.00%
Open: $115.07
Previous Close: $114.91
52 Week Range: $90.48 - $116.04
Oustanding Shares: 169,354,000
Market Cap: 19,465,548,800
6-Month Chart
TheStreet Ratings Grade for ZMH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ZMH Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ZMH:
Revenue 0.00B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.71 $1.53 $6.05 $6.55
Number of Analysts 14 6 17 17
High Estimate $1.71 $1.56 $6.06 $7.79
Low Estimate $1.70 $1.49 $6.05 $6.26
Prior Year $1.66 $1.50 $5.75 $6.05
Growth Rate (Year over Year) 2.75% 1.89% 5.25% 8.17%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Throughout this historic run, four groups have consistently led the market.
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
Dec 02, 2014 | 7:42 AM EST
Piper Jaffray Healthcare Conference (Day 1 of 2) - 12/02/14 - 12/03/14 New York City, NY
Americans are living much longer these days -- and there are a number of ways to invest.
Investing during a mid-term election can offer large returns.

Invest in Longevity Real Money Pro($)

Consider this unsexy but good value play in healthcare. 
 Hepatitis C therapies are the pacesetters.
Aug 18, 2014 | 7:22 AM EDT
ZMH was upgraded to Outperform, William Blair said. Recent pullback has created a buying opportunity, as the Biomet deal should be accr...
It's time to start buying selectively during the pullback.
Jul 28, 2014 | 7:44 AM EDT
ZMH was upgraded from Perform to Outperform, Oppenheimer said. $118 price target. Biomet deal should add to earnings, beginning in 2015...

Columnist Conversations

Under Armour has been fading since the opening bell. The stock is off just shy of 1.6% as it extends Frid...
I wrote on RMP last week that I thought CVS Health (CVS) was too pricey. Today independent research firm Trefi...
Shares of Lockheed Martin are pushing further into new all time high ground. LMT is up just shy of 2% a...
We are feeling the pain today with our long GILD calls, these things happen and is why we A. Do not oversize ...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.